홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Methanol → 1-({7-[4-(1H-imidazol-2-yl)phenyl]-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl}carbonyl)piperidine-4-carbonitrile

HRID 473905
인쇄

반응식

HRID 473905 반응식
[C:1]([CH:3]1[CH2:8][CH2:7][N:6]([C:9]([N:11]2[CH2:17][C:16]3[CH:18]=[C:19]([C:22]4[CH:27]=[CH:26][C:25]([C:28]5[N:29](C(OCC(C)C)=O)[CH:30]=[CH:31][N:32]=5)=[CH:24][CH:23]=4)[CH:20]=[CH:21][C:15]=3[O:14][CH2:13][CH2:12]2)=[O:10])[CH2:5][CH2:4]1)#[N:2].CO.C1COCC1.C(=O)([O-])[O-].[K+].[K+]>O>[NH:29]1[CH:30]=[CH:31][N:32]=[C:28]1[C:25]1[CH:26]=[CH:27][C:22]([C:19]2[CH:20]=[CH:21][C:15]3[O:14][CH2:13][CH2:12][N:11]([C:9]([N:6]4[CH2:7][CH2:8][CH:3]([C:1]#[N:2])[CH2:4][CH2:5]4)=[O:10])[CH2:17][C:16]=3[CH:18]=2)=[CH:23][CH:24]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 887MethanolHCID 8028TetrahydrofuranHCID 11430Potassium CarbonateHCID 675151332-methylpropyl 2-(4-{4-[(4-cyanopiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}phenyl)-1H-imidazole-1-carboxylate

생성물 1

HCID 498336871-({7-[4-(1H-imidazol-2-yl)phenyl]-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl}carbonyl)piperidine-4-carbonitrile
수율 65%

시약·촉매·용매 1

HCID 962Water용매

실험 절차

2-Methylpropyl 2-(4-{4-[(4-cyanopiperidin-1-yl)carbonyl]-2,3,4,5-tetrahydro-1,4-benzoxazepin-7-yl}phenyl)-1H-imidazole-1-carboxylate (296 mg, 0.56 mmol) was taken into methanol (10 mL), THF (2 mL) and water (0.5 mL) then warmed to give a homogeneous solution. Potassium carbonate (160 mg, 1.15 mmol) and the mixture was stirred for 30 minutes. The mixture was then concentrated and partitioned with ethyl acetate and 10% aqueous citric acid. The organic solution was washed with brine, dried over anhydrous sodium sulfate then filtered and concentrated. The residue was purified by silica gel chromatography (10% ethanol in ethyl acetate) to give 1-({7-[4-(1H-imidazol-2-yl)phenyl]-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl}carbonyl)piperidine-4-carbonitrile (155 mg, 65% yield). 1H NMR (400 MHz, d4-methanol): 7.92 (d, 2H), 7.69 (d, 2H), 7.56 (d, 1H), 7.51 (dd, 1H), 7.15 (s, 2H), 7.04 (d, 1H), 4.51 (s, 2H), 4.21 (tr, 2H), 3.70 (tr, 2H), 3.49-3.43 (m, 2H), 3.13 (m, 2H), 2.97 (m, 1H), 1.98-1.93 (m, 2H), 1.86-1.78 (m, 2H). MS (EI) for C25H25N5O2: 429 (MH+).

후처리

  1. temperaturethen warmed
  2. customto give a homogeneous solution
  3. concentrationThe mixture was then concentrated
  4. custompartitioned with ethyl acetate and 10% aqueous citric acid
  5. washThe organic solution was washed with brine
  6. dry with materialdried over anhydrous sodium sulfate
  7. filtrationthen filtered
  8. concentrationconcentrated
  9. customThe residue was purified by silica gel chromatography (10% ethanol in ethyl acetate)

출처 및 근거

ORD 기록
ord-80452160e92b4bd19fe3b6bee003c757
출처 데이터셋
uspto-grants-2014_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08637499B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트